Prajakta Tambe

Prajakta Tambe

Ph.D Biotechnology

Biotechnology

Prajakta Tambe, Ph.D. worked at Queen’s University Belfast on a project that focused on studying ‘Role of Tregs in Acute Respiratory Distress Syndrome'. Prajakta completed a Ph.D. in August 2020 at Agharkar Research Institute, University of Pune, India. Her work aimed to develop dendrimer-based nanoparticles for the targeted delivery of MCL-1 gene-specific siRNA to bring about apoptosis in breast and prostate cancer cells and in vivo breast cancer xenograft models.

See more

Prajakta has hands-on-experience in molecular cloning/transformation, ELISA, Tregs isolation, flow cytometry, microbiology. Her Ph.D. work involved techniques like plasmid isolation, cloning, transfections, cell culture, SDS-western blotting/real-time PCR, animal handling, in vivo cancer model development. During her Ph.D., she had a chance to publish several research articles and reviews. This provided a plethora of knowledge on writing, writing styles, reference management software, editing to very minute details, and preparing scientific illustrations.

See less

Articles from Prajakta

A bioinformatics approach for detecting SARS-CoV-2 co-infections

A bioinformatics approach for detecting SARS-CoV-2 co-infections

Natural SARS-CoV-2 antibodies persist for six months in children

Natural SARS-CoV-2 antibodies persist for six months in children

CDK6: a potential drug target for severe COVID-19

CDK6: a potential drug target for severe COVID-19

IgG Fc glycosylation: A marker for severe COVID-19

IgG Fc glycosylation: A marker for severe COVID-19

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.